S0003706

Darunavir 600mg tabs/PAC-60


Darunavir 600mg tablets, bottle pack of 60
Indicative Price : Upon Request

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Darunavir 600mg tablets, bottle pack of 60

Technical Specifications:
Each film coated tablet contains Darunavir Ethanolate, equivalent to 600mg Darunavir.
Note: tablets must be administered in combination with Ritonavir 100mg as a booster.

Therapeutic class:
Protease Inhibitor (PI)

Standard shelf life:
24 months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications:
Management of HIV-1 infection in infected adults and children above 6 years of age in combination with 100mg Ritonavir as a booster to Darunavir and in combination with at least two other antiretroviral drugs.
Administration: per mouth (PO)

Storage:
Do not store above 30ºC
Store in tightly closed original container.
Keep out of reach and sight of children.

Dispensing instructions
Dispense in original container. Do not repack

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items

Related Products